{"gene":"CD300LG","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":2006,"finding":"CD300LG (nepmucin) is exclusively expressed on capillary endothelium, localized on both apical and basolateral plasma membranes and intracellular vesicular structures. It undergoes bidirectional transcytosis in polarized MDCK epithelial cells, and when exogenously expressed on HeLa cells, it mediates uptake of IgA2 and IgM but not IgG, suggesting a role in molecular traffic across capillary endothelium.","method":"Immunoelectron microscopy, transcytosis assay in polarized MDCK cells, IgA/IgM uptake assay in HeLa cells","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (immunoelectron microscopy, transcytosis assay, ligand uptake) in a single foundational study","pmids":["16876123"],"is_preprint":false},{"year":2013,"finding":"Nepmucin/CD300LG is constitutively expressed at the luminal surface of small arterioles, venules, and capillaries in most tissues, is downregulated by TNF-α signaling in lymph nodes receiving acute inflammatory signals, is downregulated in tumors and tumor-draining lymph nodes, and is induced in HEV-like vessels of chronically inflamed pancreatic islets. Activated CD4+ T cells in inflamed pancreas express high levels of nepmucin/CD300LG ligand(s), supporting a role for nepmucin/CD300LG in pathological T cell trafficking.","method":"Immunohistochemistry, in vivo mouse models (TNF-α treatment, NOD diabetes model), direct localization experiments","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — direct localization with functional consequence, multiple tissue/disease contexts, TNF-α identified as regulator","pmids":["24376728"],"is_preprint":false},{"year":2015,"finding":"The CD300LG Arg82Cys polymorphism (rs72836561) reduces CD300LG mRNA expression in muscle and adipose tissue, and carriers show increased intramyocellular lipid content and impaired fasting forearm glucose uptake. CD300LG expression in muscle correlates with intramyocellular lipid content and forearm glucose uptake, suggesting a role for CD300LG in lipid and glucose metabolism.","method":"Hyperinsulinemic euglycemic clamp, MR spectroscopy, western blotting, quantitative PCR in human muscle and adipose tissue biopsies","journal":"BMJ open diabetes research & care","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods but single study/lab","pmids":["26336608"],"is_preprint":false},{"year":2022,"finding":"The CD300LG Arg82Cys (Cys82) polymorphism is associated with lower fasting plasma concentration of cholesterol in large HDL particles and lower ApoA1 levels in males, linking nepmucin to HDL metabolism and maturation.","method":"Population-based cohort study (Oxford BioBank, n=4522) and recall-by-genotype studies with HDL subclass measurements","journal":"Journal of the Endocrine Society","confidence":"Medium","confidence_rationale":"Tier 2 — genetic association with functional lipid phenotypes, replicated across two cohorts","pmids":["35382499"],"is_preprint":false},{"year":2024,"finding":"Serum CD300LG levels increase in response to prolonged exercise in humans, correlate positively with insulin sensitivity and angiogenesis-related gene expression in muscle and fat, and Mendelian randomization suggests a causal relationship between CD300LG levels and fasting glucose, 2-hour glucose, and HbA1c. Male Cd300lg knockout mice exhibit impaired glucose tolerance (but not female knockouts), establishing a sex-specific role for CD300LG in glucose homeostasis.","method":"Serum proteomics (12-week exercise intervention), hyperinsulinemic euglycemic clamp, MRI/MRS, mRNA sequencing, Mendelian randomization, Cd300lg knockout mouse model with glucose tolerance testing","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including KO mouse phenotype, Mendelian randomization, and human intervention study","pmids":["39190027"],"is_preprint":false},{"year":2024,"finding":"CD300LG, expressed as a transmembrane protein on tumor-associated monocytes (TAMos), is involved in TAMo-mediated reprogramming of CD8+ T cells into T central memory-like (TCM-like) cells in a cell-cell contact-dependent manner. The terminally differentiated TAMo subset CD300LGhigh ACElow mainly contributes to TCM-like cell development.","method":"Single-cell analysis, cell-cell contact assay, in vivo adoptive transfer and tumor models","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic finding with cell-contact dependence established and in vivo validation","pmids":["38386350"],"is_preprint":false},{"year":2025,"finding":"CD300LG acts as a receptor for triglyceride-rich lipoproteins (TRLs, including VLDL and chylomicrons) through a direct protein-protein interaction with ApoA4, facilitating TRL clearance at the microvascular endothelium. CD300LG deficiency in mice causes postprandial hypertriglyceridemia independent of changes in VLDL secretion, intestinal lipid absorption, or lipoprotein lipase activity. Human genetic analyses indicate reduced CD300LG protein levels are causally linked with CAD risk and increased TRL number, diameter, and TAG concentration.","method":"Mouse Cd300lg knockout model (postprandial lipid assays), direct binding/interaction assay (CD300LG–ApoA4), human genetic/Mendelian randomization analysis","journal":"bioRxiv","confidence":"High","confidence_rationale":"Tier 1 — direct binding interaction identified, KO phenotype with mechanistic dissection (ruling out LPL, VLDL secretion, absorption), Mendelian randomization in humans","pmids":["bio_10.1101_2025.08.08.669356"],"is_preprint":true}],"current_model":"CD300LG (nepmucin) is a capillary endothelial transmembrane receptor that mediates bidirectional transcytosis and selective uptake of IgA2/IgM; acts as an adhesion molecule supporting lymphocyte/leukocyte transmigration through TNF-α-regulated expression; functions as a receptor for triglyceride-rich lipoproteins via direct interaction with ApoA4 to facilitate postprandial lipid clearance at the microvascular endothelium; and plays a sex-specific role in glucose homeostasis, with its expression linked to intramyocellular lipid content, insulin sensitivity, and physical activity-induced metabolic adaptation."},"narrative":{"teleology":[{"year":2006,"claim":"The initial characterization established that CD300LG is an endothelial transmembrane protein capable of bidirectional transcytosis and selective immunoglobulin uptake (IgA2, IgM but not IgG), defining it as a molecular transporter at the capillary barrier rather than a conventional adhesion molecule.","evidence":"Immunoelectron microscopy, polarized MDCK transcytosis assay, and HeLa Ig-uptake assay","pmids":["16876123"],"confidence":"High","gaps":["Identity of the IgA2/IgM-binding domain on CD300LG was not mapped","Physiological relevance of Ig transcytosis across native endothelium not demonstrated in vivo","No loss-of-function model to confirm transport function"]},{"year":2013,"claim":"Mapping CD300LG expression across tissues and disease states revealed it is constitutively present on small-vessel endothelium, downregulated by TNF-α and in tumors, and induced on HEV-like vessels during chronic inflammation, establishing it as an inflammation-regulated vascular adhesion/trafficking molecule.","evidence":"Immunohistochemistry across mouse tissues, TNF-α treatment in vivo, NOD diabetes and tumor models","pmids":["24376728"],"confidence":"High","gaps":["The ligand(s) on activated T cells that engage CD300LG remain unidentified","Functional consequence of CD300LG loss on lymphocyte trafficking not tested with knockout or blocking antibody","Mechanism linking TNF-α signaling to CD300LG downregulation not elucidated"]},{"year":2015,"claim":"A human genetic variant (Arg82Cys) that reduces CD300LG expression was linked to increased intramyocellular lipid and impaired fasting glucose uptake, extending the protein's role from vascular biology into tissue-level lipid and glucose metabolism.","evidence":"Hyperinsulinemic euglycemic clamp, MR spectroscopy, and qPCR/western blot in human muscle and adipose biopsies","pmids":["26336608"],"confidence":"Medium","gaps":["Single study from one cohort; independent replication of glucose uptake phenotype needed","Causal direction between CD300LG expression and intramyocellular lipid accumulation not established","Molecular mechanism by which endothelial CD300LG influences myocyte lipid content unknown"]},{"year":2022,"claim":"The same Arg82Cys variant was associated with lower large-HDL cholesterol and ApoA1 levels in males, broadening the metabolic phenotype to include HDL maturation and revealing sex-specificity.","evidence":"Population-based cohort (Oxford BioBank, n=4522) and recall-by-genotype studies with HDL subclass measurements","pmids":["35382499"],"confidence":"Medium","gaps":["Mechanistic basis for the sex-specific HDL effect not determined","Whether CD300LG directly interacts with HDL particles or acts indirectly through endothelial lipid handling is unknown","No animal model validation of the HDL phenotype"]},{"year":2024,"claim":"Combined human exercise-intervention data, Mendelian randomization, and male-specific glucose intolerance in Cd300lg-knockout mice established a causal, sex-dimorphic role for CD300LG in systemic glucose homeostasis and physical activity-induced metabolic adaptation.","evidence":"Serum proteomics after 12-week exercise, hyperinsulinemic clamp, MRI/MRS, mRNA-seq, Mendelian randomization, and Cd300lg-KO mouse glucose tolerance tests","pmids":["39190027"],"confidence":"High","gaps":["Molecular basis of sex-specificity (hormonal regulation, sex-specific interactors) not identified","Whether the glucose phenotype reflects endothelial transport of insulin, glucose transporter regulation, or lipid handling is unresolved","Tissue-specific conditional knockout not performed"]},{"year":2024,"claim":"CD300LG on tumor-associated monocytes was implicated in contact-dependent reprogramming of CD8+ T cells into central memory-like cells, revealing an immune-modulatory role beyond the endothelium.","evidence":"Single-cell analysis, cell-cell contact assay, and in vivo adoptive transfer/tumor models","pmids":["38386350"],"confidence":"Medium","gaps":["The ligand on CD8+ T cells that engages monocyte CD300LG is unidentified","Whether CD300LG is necessary or merely a marker of the TAMo subset driving reprogramming requires loss-of-function validation","Generalizability beyond the specific tumor models tested is unclear"]},{"year":2025,"claim":"Identification of ApoA4 as a direct binding partner established CD300LG as a receptor for triglyceride-rich lipoproteins at the microvascular endothelium, with knockout mice showing postprandial hypertriglyceridemia independent of LPL, VLDL secretion, or intestinal absorption — providing a unified mechanism for its metabolic phenotypes.","evidence":"(preprint) Cd300lg-KO mouse postprandial lipid assays, direct CD300LG–ApoA4 binding assay, Mendelian randomization linking CD300LG levels to TRL traits and CAD risk","pmids":["bio_10.1101_2025.08.08.669356"],"confidence":"High","gaps":["Preprint not yet peer-reviewed","Structural basis of the CD300LG–ApoA4 interaction not resolved","Whether ApoA4 binding accounts for all TRL clearance by CD300LG or additional lipoprotein ligands exist is unknown"]},{"year":null,"claim":"Key unresolved questions include the structural basis of CD300LG ligand selectivity (IgA2/IgM vs ApoA4), the mechanism underlying its sex-specific metabolic effects, and whether its endothelial and monocyte functions are mediated by the same or distinct signaling pathways.","evidence":"","pmids":[],"confidence":"High","gaps":["No crystal structure or cryo-EM model of CD300LG or its ligand complexes","Tissue-specific conditional knockouts needed to dissect endothelial vs. immune cell contributions","Signaling pathways downstream of CD300LG engagement are entirely uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0038024","term_label":"cargo receptor activity","supporting_discovery_ids":[0,6]},{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[1]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[0]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2,3,4,6]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[1,5]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[0]}],"complexes":[],"partners":["APOA4"],"other_free_text":[]},"mechanistic_narrative":"CD300LG (nepmucin) is a transmembrane glycoprotein of the capillary endothelium that functions at the interface of vascular transport, immune cell trafficking, and lipid/glucose metabolism. It undergoes bidirectional transcytosis and selectively mediates uptake of IgA2 and IgM across endothelial barriers [PMID:16876123]. Its expression on small vessels is constitutive but dynamically regulated by TNF-α, being downregulated in acute inflammation and tumors yet induced on HEV-like vessels in chronically inflamed tissues, consistent with a role in leukocyte transmigration [PMID:24376728]. CD300LG influences metabolic homeostasis: a loss-of-function Arg82Cys variant is associated with increased intramyocellular lipid, impaired glucose uptake, and altered HDL metabolism [PMID:26336608, PMID:35382499], while male Cd300lg-knockout mice display impaired glucose tolerance and exercise-induced increases in serum CD300LG are causally linked to glycemic traits by Mendelian randomization [PMID:39190027]."},"prefetch_data":{"uniprot":{"accession":"Q6UXG3","full_name":"CMRF35-like molecule 9","aliases":["CD300 antigen-like family member G","Triggering receptor expressed on myeloid cells 4","TREM-4"],"length_aa":332,"mass_kda":36.1,"function":"Receptor which may mediate L-selectin-dependent lymphocyte rollings. Binds SELL in a calcium dependent manner. Binds lymphocyte (By similarity)","subcellular_location":"Apical cell membrane; Basolateral cell membrane; Endosome, multivesicular body membrane","url":"https://www.uniprot.org/uniprotkb/Q6UXG3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CD300LG","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CD300LG","total_profiled":1310},"omim":[{"mim_id":"610520","title":"CD300 ANTIGEN-LIKE FAMILY, MEMBER G; CD300LG","url":"https://www.omim.org/entry/610520"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Calyx","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adipose tissue","ntpm":123.7},{"tissue":"breast","ntpm":107.6},{"tissue":"placenta","ntpm":55.4}],"url":"https://www.proteinatlas.org/search/CD300LG"},"hgnc":{"alias_symbol":["Trem4","CLM9"],"prev_symbol":[]},"alphafold":{"accession":"Q6UXG3","domains":[{"cath_id":"2.60.40.10","chopping":"18-126","consensus_level":"high","plddt":94.7565,"start":18,"end":126},{"cath_id":"1.20.5","chopping":"250-296","consensus_level":"medium","plddt":82.764,"start":250,"end":296}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6UXG3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q6UXG3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q6UXG3-F1-predicted_aligned_error_v6.png","plddt_mean":68.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CD300LG","jax_strain_url":"https://www.jax.org/strain/search?query=CD300LG"},"sequence":{"accession":"Q6UXG3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q6UXG3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q6UXG3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6UXG3"}},"corpus_meta":[{"pmid":"31182966","id":"PMC_31182966","title":"Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer.","date":"2019","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/31182966","citation_count":265,"is_preprint":false},{"pmid":"16876123","id":"PMC_16876123","title":"CD300 antigen like family member G: A novel Ig receptor like protein exclusively expressed on capillary endothelium.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16876123","citation_count":33,"is_preprint":false},{"pmid":"31902979","id":"PMC_31902979","title":"Towards the early detection of ductal carcinoma (a common type of breast cancer) using biomarkers linked to the PPAR(γ) signaling pathway.","date":"2019","source":"Bioinformation","url":"https://pubmed.ncbi.nlm.nih.gov/31902979","citation_count":31,"is_preprint":false},{"pmid":"29590145","id":"PMC_29590145","title":"Genomic profiling of bovine corpus luteum maturation.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29590145","citation_count":30,"is_preprint":false},{"pmid":"25957429","id":"PMC_25957429","title":"Diagnostic urinary proteome profile for immunoglobulin a nephropathy.","date":"2015","source":"Iranian journal of kidney diseases","url":"https://pubmed.ncbi.nlm.nih.gov/25957429","citation_count":22,"is_preprint":false},{"pmid":"30608189","id":"PMC_30608189","title":"Systems Genetics Approaches in Rat Identify Novel Genes and Gene Networks Associated With Cardiac Conduction.","date":"2018","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/30608189","citation_count":19,"is_preprint":false},{"pmid":"24376728","id":"PMC_24376728","title":"Dynamic changes in endothelial cell adhesion molecule nepmucin/CD300LG expression under physiological and pathological conditions.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24376728","citation_count":17,"is_preprint":false},{"pmid":"31396211","id":"PMC_31396211","title":"Site-Specific DC Surface Signatures Influence CD4+ T Cell Co-stimulation and Lung-Homing.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31396211","citation_count":17,"is_preprint":false},{"pmid":"22131235","id":"PMC_22131235","title":"Search for genetic association between IgA nephropathy and candidate genes selected by function or by gene mapping at loci IGAN2 and IGAN3.","date":"2011","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/22131235","citation_count":15,"is_preprint":false},{"pmid":"26336608","id":"PMC_26336608","title":"Reduced CD300LG mRNA tissue expression, increased intramyocellular lipid content and impaired glucose metabolism in healthy male carriers of Arg82Cys in CD300LG: a novel genometabolic cross-link between CD300LG and common metabolic phenotypes.","date":"2015","source":"BMJ open diabetes research & care","url":"https://pubmed.ncbi.nlm.nih.gov/26336608","citation_count":14,"is_preprint":false},{"pmid":"35642341","id":"PMC_35642341","title":"Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia.","date":"2022","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35642341","citation_count":14,"is_preprint":false},{"pmid":"38386350","id":"PMC_38386350","title":"Tumor-Associated Monocytes Reprogram CD8+ T Cells into Central Memory-Like Cells with Potent Antitumor Effects.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/38386350","citation_count":13,"is_preprint":false},{"pmid":"32510982","id":"PMC_32510982","title":"Role of Rare and Low-Frequency Variants in Gene-Alcohol Interactions on Plasma Lipid Levels.","date":"2020","source":"Circulation. Genomic and precision medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32510982","citation_count":11,"is_preprint":false},{"pmid":"27141827","id":"PMC_27141827","title":"Double-stranded RNA analog and type I interferon regulate expression of Trem paired receptors in murine myeloid cells.","date":"2016","source":"BMC immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27141827","citation_count":10,"is_preprint":false},{"pmid":"33987034","id":"PMC_33987034","title":"Comprehensive analysis based on DNA methylation and RNA-seq reveals hypermethylation of the up-regulated WT1 gene with potential mechanisms in PAM50 subtypes of breast cancer.","date":"2021","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/33987034","citation_count":10,"is_preprint":false},{"pmid":"34256696","id":"PMC_34256696","title":"Selection for environmental variance of litter size in rabbits involves genes in pathways controlling animal resilience.","date":"2021","source":"Genetics, selection, evolution : GSE","url":"https://pubmed.ncbi.nlm.nih.gov/34256696","citation_count":9,"is_preprint":false},{"pmid":"30122569","id":"PMC_30122569","title":"Endometrial L-selectin ligand is downregulated in the mid-secretory phase during the menstrual cycle in women with adenomyosis.","date":"2018","source":"Taiwanese journal of obstetrics & gynecology","url":"https://pubmed.ncbi.nlm.nih.gov/30122569","citation_count":8,"is_preprint":false},{"pmid":"39190027","id":"PMC_39190027","title":"Serum proteomic profiling of physical activity reveals CD300LG as a novel exerkine with a potential causal link to glucose homeostasis.","date":"2024","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/39190027","citation_count":6,"is_preprint":false},{"pmid":"26977771","id":"PMC_26977771","title":"Expression Depression of CD300LG-γ in Human Pulmonary Carcinoma.","date":"2016","source":"Monoclonal antibodies in immunodiagnosis and immunotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/26977771","citation_count":6,"is_preprint":false},{"pmid":"32595829","id":"PMC_32595829","title":"Validated limited gene predictor for cervical cancer lymph node metastases.","date":"2020","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/32595829","citation_count":6,"is_preprint":false},{"pmid":"28860929","id":"PMC_28860929","title":"CD300LG improves the cytotoxic activity of CIK.","date":"2017","source":"Central-European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28860929","citation_count":5,"is_preprint":false},{"pmid":"37442189","id":"PMC_37442189","title":"Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma.","date":"2023","source":"Alternative therapies in health and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37442189","citation_count":2,"is_preprint":false},{"pmid":"39409999","id":"PMC_39409999","title":"Secondary Transcriptomic Analysis of Triple-Negative Breast Cancer Reveals Reliable Universal and Subtype-Specific Mechanistic Markers.","date":"2024","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/39409999","citation_count":2,"is_preprint":false},{"pmid":"35382499","id":"PMC_35382499","title":"The Arg82Cys Polymorphism of the Protein Nepmucin Implies a Role in HDL Metabolism.","date":"2022","source":"Journal of the Endocrine Society","url":"https://pubmed.ncbi.nlm.nih.gov/35382499","citation_count":2,"is_preprint":false},{"pmid":"40565055","id":"PMC_40565055","title":"XGB-BIF: An XGBoost-Driven Biomarker Identification Framework for Detecting Cancer Using Human Genomic Data.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40565055","citation_count":2,"is_preprint":false},{"pmid":"40382513","id":"PMC_40382513","title":"Machine learning and single-cell analysis uncover distinctive characteristics of CD300LG within the TNBC immune microenvironment: experimental validation.","date":"2025","source":"Clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40382513","citation_count":1,"is_preprint":false},{"pmid":"40082607","id":"PMC_40082607","title":"Identification of candidate biomarkers correlated with the pathogenesis of breast cancer patients.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40082607","citation_count":1,"is_preprint":false},{"pmid":"39153120","id":"PMC_39153120","title":"Adam19 Deficiency Impacts Pulmonary Function: Human GWAS Follow-up in a Mouse Knockout Model.","date":"2024","source":"Lung","url":"https://pubmed.ncbi.nlm.nih.gov/39153120","citation_count":1,"is_preprint":false},{"pmid":"40934961","id":"PMC_40934961","title":"Integrative analysis identifies novel proteins associated with chronic kidney disease in participants with abnormal glucose metabolism.","date":"2025","source":"Diabetes research and clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/40934961","citation_count":0,"is_preprint":false},{"pmid":"41251457","id":"PMC_41251457","title":"Rewiring the luteal microenvironment: hemodynamic and molecular insights into eCG-supported CL development in indigenous White Lamphun cattle.","date":"2025","source":"Reproduction & fertility","url":"https://pubmed.ncbi.nlm.nih.gov/41251457","citation_count":0,"is_preprint":false},{"pmid":"38659817","id":"PMC_38659817","title":"Adam19 Deficiency Impacts Pulmonary Function: Human GWAS Follow-up in Mouse.","date":"2024","source":"Research square","url":"https://pubmed.ncbi.nlm.nih.gov/38659817","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.08.08.669356","title":"CD300LG is a receptor for triglyceride-rich lipoproteins that facilitates postprandial lipid clearance","date":"2025-08-12","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.08.669356","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":20309,"output_tokens":1961,"usd":0.045171},"stage2":{"model":"claude-opus-4-6","input_tokens":5236,"output_tokens":2355,"usd":0.127582},"total_usd":0.172753,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"CD300LG (nepmucin) is exclusively expressed on capillary endothelium, localized on both apical and basolateral plasma membranes and intracellular vesicular structures. It undergoes bidirectional transcytosis in polarized MDCK epithelial cells, and when exogenously expressed on HeLa cells, it mediates uptake of IgA2 and IgM but not IgG, suggesting a role in molecular traffic across capillary endothelium.\",\n      \"method\": \"Immunoelectron microscopy, transcytosis assay in polarized MDCK cells, IgA/IgM uptake assay in HeLa cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (immunoelectron microscopy, transcytosis assay, ligand uptake) in a single foundational study\",\n      \"pmids\": [\"16876123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Nepmucin/CD300LG is constitutively expressed at the luminal surface of small arterioles, venules, and capillaries in most tissues, is downregulated by TNF-α signaling in lymph nodes receiving acute inflammatory signals, is downregulated in tumors and tumor-draining lymph nodes, and is induced in HEV-like vessels of chronically inflamed pancreatic islets. Activated CD4+ T cells in inflamed pancreas express high levels of nepmucin/CD300LG ligand(s), supporting a role for nepmucin/CD300LG in pathological T cell trafficking.\",\n      \"method\": \"Immunohistochemistry, in vivo mouse models (TNF-α treatment, NOD diabetes model), direct localization experiments\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with functional consequence, multiple tissue/disease contexts, TNF-α identified as regulator\",\n      \"pmids\": [\"24376728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The CD300LG Arg82Cys polymorphism (rs72836561) reduces CD300LG mRNA expression in muscle and adipose tissue, and carriers show increased intramyocellular lipid content and impaired fasting forearm glucose uptake. CD300LG expression in muscle correlates with intramyocellular lipid content and forearm glucose uptake, suggesting a role for CD300LG in lipid and glucose metabolism.\",\n      \"method\": \"Hyperinsulinemic euglycemic clamp, MR spectroscopy, western blotting, quantitative PCR in human muscle and adipose tissue biopsies\",\n      \"journal\": \"BMJ open diabetes research & care\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods but single study/lab\",\n      \"pmids\": [\"26336608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The CD300LG Arg82Cys (Cys82) polymorphism is associated with lower fasting plasma concentration of cholesterol in large HDL particles and lower ApoA1 levels in males, linking nepmucin to HDL metabolism and maturation.\",\n      \"method\": \"Population-based cohort study (Oxford BioBank, n=4522) and recall-by-genotype studies with HDL subclass measurements\",\n      \"journal\": \"Journal of the Endocrine Society\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic association with functional lipid phenotypes, replicated across two cohorts\",\n      \"pmids\": [\"35382499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Serum CD300LG levels increase in response to prolonged exercise in humans, correlate positively with insulin sensitivity and angiogenesis-related gene expression in muscle and fat, and Mendelian randomization suggests a causal relationship between CD300LG levels and fasting glucose, 2-hour glucose, and HbA1c. Male Cd300lg knockout mice exhibit impaired glucose tolerance (but not female knockouts), establishing a sex-specific role for CD300LG in glucose homeostasis.\",\n      \"method\": \"Serum proteomics (12-week exercise intervention), hyperinsulinemic euglycemic clamp, MRI/MRS, mRNA sequencing, Mendelian randomization, Cd300lg knockout mouse model with glucose tolerance testing\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including KO mouse phenotype, Mendelian randomization, and human intervention study\",\n      \"pmids\": [\"39190027\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CD300LG, expressed as a transmembrane protein on tumor-associated monocytes (TAMos), is involved in TAMo-mediated reprogramming of CD8+ T cells into T central memory-like (TCM-like) cells in a cell-cell contact-dependent manner. The terminally differentiated TAMo subset CD300LGhigh ACElow mainly contributes to TCM-like cell development.\",\n      \"method\": \"Single-cell analysis, cell-cell contact assay, in vivo adoptive transfer and tumor models\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic finding with cell-contact dependence established and in vivo validation\",\n      \"pmids\": [\"38386350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CD300LG acts as a receptor for triglyceride-rich lipoproteins (TRLs, including VLDL and chylomicrons) through a direct protein-protein interaction with ApoA4, facilitating TRL clearance at the microvascular endothelium. CD300LG deficiency in mice causes postprandial hypertriglyceridemia independent of changes in VLDL secretion, intestinal lipid absorption, or lipoprotein lipase activity. Human genetic analyses indicate reduced CD300LG protein levels are causally linked with CAD risk and increased TRL number, diameter, and TAG concentration.\",\n      \"method\": \"Mouse Cd300lg knockout model (postprandial lipid assays), direct binding/interaction assay (CD300LG–ApoA4), human genetic/Mendelian randomization analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct binding interaction identified, KO phenotype with mechanistic dissection (ruling out LPL, VLDL secretion, absorption), Mendelian randomization in humans\",\n      \"pmids\": [\"bio_10.1101_2025.08.08.669356\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"CD300LG (nepmucin) is a capillary endothelial transmembrane receptor that mediates bidirectional transcytosis and selective uptake of IgA2/IgM; acts as an adhesion molecule supporting lymphocyte/leukocyte transmigration through TNF-α-regulated expression; functions as a receptor for triglyceride-rich lipoproteins via direct interaction with ApoA4 to facilitate postprandial lipid clearance at the microvascular endothelium; and plays a sex-specific role in glucose homeostasis, with its expression linked to intramyocellular lipid content, insulin sensitivity, and physical activity-induced metabolic adaptation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CD300LG (nepmucin) is a transmembrane glycoprotein of the capillary endothelium that functions at the interface of vascular transport, immune cell trafficking, and lipid/glucose metabolism. It undergoes bidirectional transcytosis and selectively mediates uptake of IgA2 and IgM across endothelial barriers [PMID:16876123]. Its expression on small vessels is constitutive but dynamically regulated by TNF-α, being downregulated in acute inflammation and tumors yet induced on HEV-like vessels in chronically inflamed tissues, consistent with a role in leukocyte transmigration [PMID:24376728]. CD300LG influences metabolic homeostasis: a loss-of-function Arg82Cys variant is associated with increased intramyocellular lipid, impaired glucose uptake, and altered HDL metabolism [PMID:26336608, PMID:35382499], while male Cd300lg-knockout mice display impaired glucose tolerance and exercise-induced increases in serum CD300LG are causally linked to glycemic traits by Mendelian randomization [PMID:39190027].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"The initial characterization established that CD300LG is an endothelial transmembrane protein capable of bidirectional transcytosis and selective immunoglobulin uptake (IgA2, IgM but not IgG), defining it as a molecular transporter at the capillary barrier rather than a conventional adhesion molecule.\",\n      \"evidence\": \"Immunoelectron microscopy, polarized MDCK transcytosis assay, and HeLa Ig-uptake assay\",\n      \"pmids\": [\"16876123\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity of the IgA2/IgM-binding domain on CD300LG was not mapped\",\n        \"Physiological relevance of Ig transcytosis across native endothelium not demonstrated in vivo\",\n        \"No loss-of-function model to confirm transport function\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Mapping CD300LG expression across tissues and disease states revealed it is constitutively present on small-vessel endothelium, downregulated by TNF-α and in tumors, and induced on HEV-like vessels during chronic inflammation, establishing it as an inflammation-regulated vascular adhesion/trafficking molecule.\",\n      \"evidence\": \"Immunohistochemistry across mouse tissues, TNF-α treatment in vivo, NOD diabetes and tumor models\",\n      \"pmids\": [\"24376728\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The ligand(s) on activated T cells that engage CD300LG remain unidentified\",\n        \"Functional consequence of CD300LG loss on lymphocyte trafficking not tested with knockout or blocking antibody\",\n        \"Mechanism linking TNF-α signaling to CD300LG downregulation not elucidated\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"A human genetic variant (Arg82Cys) that reduces CD300LG expression was linked to increased intramyocellular lipid and impaired fasting glucose uptake, extending the protein's role from vascular biology into tissue-level lipid and glucose metabolism.\",\n      \"evidence\": \"Hyperinsulinemic euglycemic clamp, MR spectroscopy, and qPCR/western blot in human muscle and adipose biopsies\",\n      \"pmids\": [\"26336608\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single study from one cohort; independent replication of glucose uptake phenotype needed\",\n        \"Causal direction between CD300LG expression and intramyocellular lipid accumulation not established\",\n        \"Molecular mechanism by which endothelial CD300LG influences myocyte lipid content unknown\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"The same Arg82Cys variant was associated with lower large-HDL cholesterol and ApoA1 levels in males, broadening the metabolic phenotype to include HDL maturation and revealing sex-specificity.\",\n      \"evidence\": \"Population-based cohort (Oxford BioBank, n=4522) and recall-by-genotype studies with HDL subclass measurements\",\n      \"pmids\": [\"35382499\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanistic basis for the sex-specific HDL effect not determined\",\n        \"Whether CD300LG directly interacts with HDL particles or acts indirectly through endothelial lipid handling is unknown\",\n        \"No animal model validation of the HDL phenotype\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Combined human exercise-intervention data, Mendelian randomization, and male-specific glucose intolerance in Cd300lg-knockout mice established a causal, sex-dimorphic role for CD300LG in systemic glucose homeostasis and physical activity-induced metabolic adaptation.\",\n      \"evidence\": \"Serum proteomics after 12-week exercise, hyperinsulinemic clamp, MRI/MRS, mRNA-seq, Mendelian randomization, and Cd300lg-KO mouse glucose tolerance tests\",\n      \"pmids\": [\"39190027\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular basis of sex-specificity (hormonal regulation, sex-specific interactors) not identified\",\n        \"Whether the glucose phenotype reflects endothelial transport of insulin, glucose transporter regulation, or lipid handling is unresolved\",\n        \"Tissue-specific conditional knockout not performed\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"CD300LG on tumor-associated monocytes was implicated in contact-dependent reprogramming of CD8+ T cells into central memory-like cells, revealing an immune-modulatory role beyond the endothelium.\",\n      \"evidence\": \"Single-cell analysis, cell-cell contact assay, and in vivo adoptive transfer/tumor models\",\n      \"pmids\": [\"38386350\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The ligand on CD8+ T cells that engages monocyte CD300LG is unidentified\",\n        \"Whether CD300LG is necessary or merely a marker of the TAMo subset driving reprogramming requires loss-of-function validation\",\n        \"Generalizability beyond the specific tumor models tested is unclear\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identification of ApoA4 as a direct binding partner established CD300LG as a receptor for triglyceride-rich lipoproteins at the microvascular endothelium, with knockout mice showing postprandial hypertriglyceridemia independent of LPL, VLDL secretion, or intestinal absorption — providing a unified mechanism for its metabolic phenotypes.\",\n      \"evidence\": \"(preprint) Cd300lg-KO mouse postprandial lipid assays, direct CD300LG–ApoA4 binding assay, Mendelian randomization linking CD300LG levels to TRL traits and CAD risk\",\n      \"pmids\": [\"bio_10.1101_2025.08.08.669356\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Preprint not yet peer-reviewed\",\n        \"Structural basis of the CD300LG–ApoA4 interaction not resolved\",\n        \"Whether ApoA4 binding accounts for all TRL clearance by CD300LG or additional lipoprotein ligands exist is unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of CD300LG ligand selectivity (IgA2/IgM vs ApoA4), the mechanism underlying its sex-specific metabolic effects, and whether its endothelial and monocyte functions are mediated by the same or distinct signaling pathways.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No crystal structure or cryo-EM model of CD300LG or its ligand complexes\",\n        \"Tissue-specific conditional knockouts needed to dissect endothelial vs. immune cell contributions\",\n        \"Signaling pathways downstream of CD300LG engagement are entirely uncharacterized\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0038024\", \"supporting_discovery_ids\": [0, 6]},\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2, 3, 4, 6]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"APOA4\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}